Zotefoams Plc Record third quarter sales performance

Zotefoams Plc

Zotefoams Plc (LON:ZTF), a world leader in cellular materials technology, today provided a trading update for the third quarter ended 30 September 2018.

Zotefoams is pleased to report a record third quarter sales performance. Using foreign exchange rates as at 30 September 2018, full-year revenues and profit before tax are now expected to be slightly ahead of consensus market expectations.

In the nine months ended 30 September 2018, the Group has recorded:

· 16% increase in Group revenues against the comparative period, 18% in constant currency

· 7% growth in Polyolefin foams (72% of Group revenue)

o Improved sales mix

o Additional capacity contributing to 5% higher sales volumes;

· 97% increase in HPP sales (26% of Group revenue)

o Increased product adoption by end-users delivered very strong growth in our ZOTEK® PEBA elastomeric foams used in performance footwear;

o Strong recovery in ZOTEK® F fluoropolymer foams mainly from aviation applications;

o Orders for T-FIT® insulation products, down slightly year-to-date, are more strongly weighted in the final quarter this year, with annual growth in this product range dependent upon timing of shipments in the final quarter;

· MuCell Extrusion (2% of Group revenue)

o Year-to-date sales fell by 21%, excluding the one-off equipment sale in 2017;

o Q3 sales were impacted as a result of our internal restructuring, described in our interim results statement, which absorbed resource;

o MuCell Extrusion is being re-focused to develop the full potential of its technology;

· Capacity expansion programmes in the UK and USA are progressing well, with planned commissioning in 2019, while the announced new capacity in Poland is planned to come on stream in 2020.

Commenting on the update David Stirling, Group CEO of Zotefoams, said:

“We expect 2018 to be another year of substantial progress for the Group: growing revenue, developing our portfolio of opportunities supported by committed capacity investments and enhancing our talent pool. We remain confident about the future prospects of the business.”

Share on:

Latest Company News

Zotefoams adds sales leadership to support growth targets

Zotefoams has strengthened its EMEA and North American sales teams as it targets higher revenue and operating profit by FY29.

Zotefoams outlines 2025 financial performance and sets 2026 AGM

Zotefoams plc has released its 2025 Annual Report, detailing full-year financial performance and management commentary, including reviews from the Chair, Group CEO and CFO.

Zotefoams reports record FY2025 profits and margin growth

Zotefoams plc posted record revenue of £158.5m and a 26% rise in adjusted operating profit to £22.8m for FY2025, supported by strong cash generation and strategic investment.

Zotefoams reports record profits and 7.2% revenue growth for FY2025

Zotefoams expects full-year revenue of £158.5m for the year ended 31 December 2025, up 7.2% year on year and ahead of market expectations.

Zotefoams delivers consistent Q3 performance and strategic progress

Zotefoams maintained positive trading momentum through Q3 2025, reporting revenue of £38.2 million, aligned with Board expectations and comparable to a strong prior year.

Zotefoams appoints Jack Clarke as Independent Non-Executive Director and incoming Audit Chair

Zotefoams has appointed Jack Clarke as an independent Non-Executive Director effective 28 October 2025. Clarke, formerly CFO of Essentra and Marshalls, brings extensive strategy and finance experience and will join the Audit, Nomination and Remuneration Committees.

    Search